Black Diamond Therapeutics Inc (NASDAQ:BDTX) price on current trading day, rose 2.38% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.72.
A look at the stock’s price movement, the close in the last trading session was $1.68, moving within a range at $1.71 and $2.78. The beta value (5-Year monthly) was 2.522. Turning to its 52-week performance, $7.66 and $1.59 were the 52-week high and 52-week low respectively. Overall, BDTX moved -24.56% over the past month.
Black Diamond Therapeutics Inc’s market cap currently stands at around $97.46 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-05.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BDTX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend BDTX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
BDTX’s current price about -8.68% and -20.38% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 38.33, while 7-day volatility ratio is 17.54% and 10.38% in the 30-day chart. Further, Black Diamond Therapeutics Inc (BDTX) has a beta value of 2.79, and an average true range (ATR) of 0.22. Analysts have given the company’s stock an average 52-week price target of $14, forecast between a low of $11 and high of $20. Looking at the price targets, the low is -539.53% off current price level while to achieve the yearly target high, price needs to move -1062.79%. Nonetheless, investors will most likely welcome a -713.95% jump to $14 which is the analysts’ median price.
If we refocus on Black Diamond Therapeutics Inc (NASDAQ:BDTX), historical trading data shows that trading volumes averaged 11.76 over the past 10 days and 768.64K over the past 3 months. The company’s latest data on shares outstanding shows there are 56.64 million shares.
The 23.83% of Black Diamond Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 75.06% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.41 million on 2025-02-28, giving us a short ratio of 13.94. The data shows that as of 2025-02-28 short interest in Black Diamond Therapeutics Inc (BDTX) stood at 2199.0 of shares outstanding, with shares short rising to 7.05 million registered in 2025-01-31. Current price change has pushed the stock -19.63% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BDTX stock continues to rise going into the next quarter.
